Teladoc Health, Inc. (NYSE:TDOC) Given Average Rating of “Hold” by Analysts

Shares of Teladoc Health, Inc. (NYSE:TDOC) have been given an average rating of “Hold” by the sixteen brokerages that are presently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, twelve have issued a hold recommendation and three have issued a buy recommendation on the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is $9.1154.

Several equities analysts have weighed in on TDOC shares. Evercore ISI lowered their price objective on shares of Teladoc Health from $9.00 to $8.00 and set an “in-line” rating on the stock in a research report on Thursday, October 30th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Teladoc Health in a report on Monday, December 29th. Barclays began coverage on Teladoc Health in a research note on Tuesday, December 9th. They issued an “equal weight” rating and a $8.50 price objective for the company. Zacks Research cut Teladoc Health from a “strong-buy” rating to a “hold” rating in a research note on Monday, November 10th. Finally, BMO Capital Markets initiated coverage on Teladoc Health in a report on Thursday, November 13th. They issued a “market perform” rating and a $8.00 target price on the stock.

Insider Activity at Teladoc Health

In related news, insider Fernando M. Rodrigues sold 4,209 shares of the stock in a transaction on Wednesday, December 3rd. The stock was sold at an average price of $7.48, for a total transaction of $31,483.32. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Charles Divita III sold 17,138 shares of Teladoc Health stock in a transaction on Thursday, December 11th. The shares were sold at an average price of $7.63, for a total value of $130,762.94. Following the sale, the chief executive officer directly owned 201,036 shares of the company’s stock, valued at approximately $1,533,904.68. The trade was a 7.86% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 33,288 shares of company stock worth $251,684 in the last quarter. 0.58% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Teladoc Health

Several institutional investors have recently bought and sold shares of TDOC. IFP Advisors Inc boosted its position in shares of Teladoc Health by 412.1% in the third quarter. IFP Advisors Inc now owns 3,989 shares of the health services provider’s stock valued at $31,000 after acquiring an additional 3,210 shares during the period. Aster Capital Management DIFC Ltd increased its position in Teladoc Health by 101.1% during the third quarter. Aster Capital Management DIFC Ltd now owns 4,823 shares of the health services provider’s stock worth $37,000 after acquiring an additional 2,425 shares during the period. International Assets Investment Management LLC acquired a new position in Teladoc Health during the 4th quarter valued at $45,000. Bayforest Capital Ltd bought a new stake in Teladoc Health in the 3rd quarter valued at $58,000. Finally, KBC Group NV boosted its holdings in Teladoc Health by 88.3% in the 4th quarter. KBC Group NV now owns 9,632 shares of the health services provider’s stock valued at $67,000 after purchasing an additional 4,516 shares during the period. 76.82% of the stock is currently owned by institutional investors.

Teladoc Health Stock Performance

Teladoc Health stock opened at $4.74 on Friday. Teladoc Health has a fifty-two week low of $4.70 and a fifty-two week high of $15.21. The firm’s 50 day simple moving average is $6.86 and its 200-day simple moving average is $7.51. The company has a debt-to-equity ratio of 0.71, a current ratio of 2.70 and a quick ratio of 2.60. The company has a market cap of $840.33 million, a P/E ratio of -3.70 and a beta of 2.12.

About Teladoc Health

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.